COVID 19 and Immunity Issues Current Treatment Options скачать в хорошем качестве

COVID 19 and Immunity Issues Current Treatment Options

COVID-19 has affected each and every one of us but especially coronavirus has had a huge impact on those living with secondary immunodeficiencies. Dr. S. Mustafa joins President and CEO of Allergy & Asthma Network, Tonya Winders, to discuss COVID-19 and upcoming treatment issues for those with secondary immunodeficiencies. UPDATE: This video is a few years old. It may or may not be current. _______________________________ Visit the following pages for more updated information on Covid-19: https://allergyasthmanetwork.org/heal... https://allergyasthmanetwork.org/heal... First, Tonya Winders, explains the current state of COVID-19 as of Jan 20, 2022 (when the webinar aired) with the number of cases and what the latest updates are regarding COVID. She also talks about the risk of severe disease among hospitalized adults with asthma or COPD. Dr. Mustafa then goes on to talk about community and immunity issues, immunity components, and then causes of immundeficiency. Both infections and certain medications can cause immunodeficienies in some by lowering antibody counts. Dr. Mustafa also explains the COVID-19 vaccine in blood cancers and how it reacts in the body. He discusses inflammatory conditions and how those react with COVID-19 and the vaccine. He ends this segment talking about the mRNA for the 3rd dose of the COVID-19 vaccine. In the next section, Dr. Mustafa moves on to discuss management options for COVID as of January 20, 2022. COVID-19 prophylaxis, monoclonal antibodies, and oral antivirals are explained. He then finishes the webinar with a summary and by answering questions from the audience. Covid 19 Prevention & Treatment For Immunodeficiency 0:01 - Welcome 1:40 - Dr. Mustafa Introduction 4:11 - State of COVID-19 as of January 20, 2022 6:00 - In the News 11:21 - Risk for Severe Disease Among Adults Hospitalized with Asthma or COPD 14:29 - Immunity Issues 17:15 - Risk of Infection Due to Medications 18:49 - Vaccination in Immunodeficiency 22:35 - COVID-19 in Inflammatory Conditions 24:17 - COVID-19 mRNA in Vaccine 3rd Dose 26:31 - Management Options for COVID-19 31:09 - Monoclonal Antibody Treatment 33:37 - Oral Antiviral Treatment 35:18 - Summary 41:13 - Questions Asthma is a respiratory disease that affects your lungs and airways. It causes coughing, wheezing, shortness of breath and chest tightness. Asthma can be life-threatening if not treated properly. We all know how important it is to manage asthma the right way, but did you know that asthma is common among children? More than 6 million children have asthma in the United States. About 90% of those children developed asthma before the age of 6. Asthma is more common in children with allergies, eczema, or hay fever. If you have a child diagnosed with asthma, work with your child's pediatrician to create an Asthma Action Plan. This will help you and your child manage asthma, avoid triggers and prevent symptoms. More from the Allergy & Asthma Network: https://allergyasthmanetwork.org/heal...